Tempus AI, Inc. Class A (TEM) Stock Forecast & Price Target

― Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

TEM Analyst Ratings

Moderate Buy

8 Buy

7 Hold

0 Sell

Based on 15 analysts giving stock ratings to

Tempus

AI, Inc. Class A

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

TEM Stock 12 Month Forecast

Average Price Target

$1,151.54

Based on 15 Wall Street analysts offering 12 month price targets for Tempus AI, Inc. Class A in the last 3 months. The average price target is $1,151.54 with a high forecast of $1,400.71 and a low forecast of $875.44. The average price target represents a ― change from the last price of ―.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"829":"$829","1240":"$1,240","1651":"$1,651","1034.5":"$1,034.5","1445.5":"$1,445.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1400.7073576,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.40K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1151.5430680269228,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.15K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":875.4420985,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$875.44</span>\n  </div></div>","useHTML":true}}],"tickPositions":[829,1034.5,1240,1445.5,1651],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1085,1109.2851813538462,1133.5703627076923,1157.8555440615385,1182.1407254153846,1206.4259067692308,1230.711088123077,1254.996269476923,1279.2814508307692,1303.5666321846154,1327.8518135384616,1352.1369948923077,1376.4221762461539,{"y":1400.7073576,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1085,1090.1186975405326,1095.237395081065,1100.3560926215976,1105.4747901621301,1110.5934877026625,1115.712185243195,1120.8308827837277,1125.9495803242603,1131.0682778647927,1136.1869754053253,1141.3056729458579,1146.4243704863902,{"y":1151.5430680269228,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1085,1068.880161423077,1052.760322846154,1036.6404842692307,1020.5206456923077,1004.4008071153846,988.2809685384616,972.1611299615384,956.0412913846154,939.9214528076923,923.8016142307692,907.6817756538462,891.5619370769232,{"y":875.4420985,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1120,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1025,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1373,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1580.78,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1650,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1405,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1061,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1078,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":902,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":830,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":865,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":920.28,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1085,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$1,401

Average Price Target$1,152

Lowest Price Target$875.44

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Yi Chen

H.C. Wainwright

$1,120.57

Buy

―

Reiterated

07/24/26

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (NASDAQ: TEM), Brainsway (NASDAQ: BWAY) and Argenx Se (NASDAQ: ARGX)

Matt Larew

William Blair

―

Hold

―

Assigned

07/21/26

Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (NASDAQ: FDMT) and Tempus AI, Inc. Class A (NASDAQ: TEM)

Kyle Mikson CFA

Canaccord Genuity

$1,400.71

Buy

―

Reiterated

07/20/26

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (NASDAQ: TEM), AdaptHealth (NASDAQ: AHCO) and Argenx Se (NASDAQ: ARGX)

Michael Ryskin

Bank of America Securities

$1,120.57

Hold

―

Reiterated

07/20/26

Analysts Are Neutral on These Healthcare Stocks: Cencora (COR), Avita Medical (RCEL)

Ryan MacDonald

Needham

$1,313.16

Buy

―

Reiterated

07/20/26

Tempus AI: Buy Rating Reaffirmed as Personalis Deal Strengthens MRD Position; $75 Price Target Maintained

Subbu Nambi

Guggenheim

$1,050.53→$1,138.07

Buy

―

Reiterated

07/15/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Daniel Brennan

TD Cowen

$1,190.6→$1,243.13

Buy

―

Reiterated

07/15/26

Tempus AI price target raised to $71 from $68 at TD CowenTempus AI price target raised to $71 from $68 at TD Cowen

Kallum Titchmarsh

Morgan Stanley

$1,225.62

Buy

―

Reiterated

07/10/26

Morgan Stanley Remains a Buy on Tempus AI, Inc. Class A (TEM)

Eugene Mannheimer

Freedom Capital Markets

$1,033.02

Hold

―

Initiated

06/30/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: LivaNova (NASDAQ: LIVN), Gain Therapeutics (NASDAQ: GANX) and Tempus AI, Inc. Class A (NASDAQ: TEM)

Daniel Arias

Stifel Nicolaus

$1,050.53

Hold

―

Reiterated

06/01/26

Stifel Nicolaus Sticks to Its Hold Rating for Tempus AI, Inc. Class A (TEM)

Casey Woodring

J.P. Morgan

$875.44

Hold

―

Reiterated

06/01/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (NASDAQ: KRYS), AbbVie (NYSE: ABBV) and Tempus AI, Inc. Class A (NASDAQ: TEM)

Mark Massaro

BTIG

$1,400.71

Buy

―

Reiterated

06/01/26

BTIG Keeps Their Buy Rating on Tempus AI, Inc. Class A (TEM)

David Westenberg

Piper Sandler

$1,015.51

Hold

―

Reiterated

05/12/26

Piper Sandler Sticks to Their Hold Rating for Tempus AI, Inc. Class A (TEM)

Catherine Ramsey Schulte

Robert W. Baird

$1,190.6→$1,033.02

Buy

―

Reiterated

05/06/26

Tempus AI price target lowered to $59 from $68 at BairdTempus AI price target lowered to $59 from $68 at Baird

Anthony Petrone

Mizuho Securities

$857.93→$1,750.88

Buy

―

Reiterated

04/13/26

Mizuho Securities Keeps Their Buy Rating on Tempus AI, Inc. Class A (TEM)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Yi Chen

H.C. Wainwright

$1,120.57

Buy

―

Reiterated

07/24/26

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (NASDAQ: TEM), Brainsway (NASDAQ: BWAY) and Argenx Se (NASDAQ: ARGX)

Matt Larew

William Blair

―

Hold

―

Assigned

07/21/26

Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (NASDAQ: FDMT) and Tempus AI, Inc. Class A (NASDAQ: TEM)

Kyle Mikson CFA

Canaccord Genuity

$1,400.71

Buy

―

Reiterated

07/20/26

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (NASDAQ: TEM), AdaptHealth (NASDAQ: AHCO) and Argenx Se (NASDAQ: ARGX)

Michael Ryskin

Bank of America Securities

$1,120.57

Hold

―

Reiterated

07/20/26

Analysts Are Neutral on These Healthcare Stocks: Cencora (COR), Avita Medical (RCEL)

Ryan MacDonald

Needham

$1,313.16

Buy

―

Reiterated

07/20/26

Tempus AI: Buy Rating Reaffirmed as Personalis Deal Strengthens MRD Position; $75 Price Target Maintained

Subbu Nambi

Guggenheim

$1,050.53→$1,138.07

Buy

―

Reiterated

07/15/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Daniel Brennan

TD Cowen

$1,190.6→$1,243.13

Buy

―

Reiterated

07/15/26

Tempus AI price target raised to $71 from $68 at TD CowenTempus AI price target raised to $71 from $68 at TD Cowen

Kallum Titchmarsh

Morgan Stanley

$1,225.62

Buy

―

Reiterated

07/10/26

Morgan Stanley Remains a Buy on Tempus AI, Inc. Class A (TEM)

Eugene Mannheimer

Freedom Capital Markets

$1,033.02

Hold

―

Initiated

06/30/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: LivaNova (NASDAQ: LIVN), Gain Therapeutics (NASDAQ: GANX) and Tempus AI, Inc. Class A (NASDAQ: TEM)

Daniel Arias

Stifel Nicolaus

$1,050.53

Hold

―

Reiterated

06/01/26

Stifel Nicolaus Sticks to Its Hold Rating for Tempus AI, Inc. Class A (TEM)

Casey Woodring

J.P. Morgan

$875.44

Hold

―

Reiterated

06/01/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (NASDAQ: KRYS), AbbVie (NYSE: ABBV) and Tempus AI, Inc. Class A (NASDAQ: TEM)

Mark Massaro

BTIG

$1,400.71

Buy

―

Reiterated

06/01/26

BTIG Keeps Their Buy Rating on Tempus AI, Inc. Class A (TEM)

David Westenberg

Piper Sandler

$1,015.51

Hold

―

Reiterated

05/12/26

Piper Sandler Sticks to Their Hold Rating for Tempus AI, Inc. Class A (TEM)

Catherine Ramsey Schulte

Robert W. Baird

$1,190.6→$1,033.02

Buy

―

Reiterated

05/06/26

Tempus AI price target lowered to $59 from $68 at BairdTempus AI price target lowered to $59 from $68 at Baird

Anthony Petrone

Mizuho Securities

$857.93→$1,750.88

Buy

―

Reiterated

04/13/26

Mizuho Securities Keeps Their Buy Rating on Tempus AI, Inc. Class A (TEM)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

GKOSGlaukos

ARDXArdelyx

STOKStoke Therapeutics

MIRMMirum Pharmaceuticals

CSTLCastle Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Tempus AI, Inc. Class A

3 Months

Ryan MacDonaldNeedham

Success Rate

8/15 ratings generated profit

Average Return

+10.80%

Copying Ryan MacDonald's trades and holding each position for 3 Months would result in 53.33% of your transactions generating a profit, with an average return of +10.80% per trade.

1 Year

Daniel BrennanTD Cowen

Success Rate

7/12 ratings generated profit

Average Return

+22.67%

Copying Daniel Brennan's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +22.67% per trade.

2 Years

Daniel BrennanTD Cowen

Success Rate

7/12 ratings generated profit

Average Return

+37.33%

Copying Daniel Brennan's trades and holding each position for 2 Years would result in 58.33% of your transactions generating a profit, with an average return of +37.33% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TEM Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, TEM has received 21 Buy Ratings, 14 Hold Ratings, and 0 Sell Ratings. TEM average Analyst price target in the past 3 months is 1,151.54.

Each month's total comprises the sum of three months' worth of ratings.

TEM Financial Forecast

No data currently available

TEM Earnings Forecast

Currently, no earnings data available.

No data currently available

TEM Sales Forecast

Currently, no sales data available.

TEM Stock Forecast FAQ

What is MX:TEM’s average 12-month price target, according to analysts?

Based on analyst ratings, Tempus AI, Inc. Class A’s 12-month average price target is 1,151.54.

What is MX:TEM’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for MX:TEM, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Tempus AI, Inc. Class A a Buy, Sell or Hold?

Tempus AI, Inc. Class A has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 7 hold ratings and 0 sell ratings.

What is Tempus AI, Inc. Class A’s share price target?

The average share price target for Tempus AI, Inc. Class A is 1,151.54. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $1,400.71 ,and the lowest forecast is $875.44. The average share price target represents N/A Increase from the current price of N/A.

What do analysts say about Tempus AI, Inc. Class A?

Tempus AI, Inc. Class A’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.

How can I buy shares of Tempus AI, Inc. Class A?

To buy shares of MX:TEM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Tempus AI, Inc. Class A (TEM) Stock Forecast & Price Target

TEM Analyst Ratings

TEM Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Tempus AI, Inc. Class A

TEM Analyst Recommendation Trends

TEM Financial Forecast

TEM Earnings Forecast

TEM Sales Forecast

TEM Stock Forecast FAQ

Detailed List of Analyst Forecasts